Latest News

FDA announces safety monitoring measures for the essure device




(HealthDay)—The U.S. Food and Drug Administration is implementing a number of steps for long-term safety monitoring of the permanent birth control device Essure, which will no longer be sold or distributed in the United States after Dec. 31, 2018.

Source link





Related posts

STAT Plus: At JPM, a debate on Alzheimer’s disease, some family drama in oncology, and a beaten-down biotech

Newsemia

Hydrogel Harvests Nitric Oxide to Stop Damage from Rheumatoid Arthritis

Newsemia

Parkinson’s Disease Facts Your Doctor Is Not Telling You

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy